Tag: newswire

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

شنغهاي، الصين, June 13, 2026 (GLOBE NEWSWIRE) -- في خطوة تشكل محطة بارزة لقطاع السيارات الكهربائية الفاخرة عالمياً، سجلت سيارة «فريلاندر 8» (FREELANDER 8) ظهورها العلني الأول خلال فعاليات "منتدى أبوظبي للاستثمار - جلسة شنغهاي الخاصة" الذي عُقد في فندق "ذا بنينسولا شنغهاي" في 11 يونيو 2026. ويأتي هذا العرض الأولي في الوقت الذي تستعد فيه العلامة التجارية الفاخرة لإطلاق هويتها رسمياً في منطقة الشرق الأوسط من العاصمة الإماراتية أبوظبي.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Calix To Contact Him Directly To Discuss Their Options

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.¹ The results showed that TALVEY^® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).¹ Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.¹  

Kaunas, Lithuania, June 13, 2026 (GLOBE NEWSWIRE) --

An informational overview examining EpiCooler Portable AC Product Details, Publicly available product disclosures and what consumers often consider when researching portable cooling devices in 2026

MIAMI, FL, June 13, 2026 (GLOBE NEWSWIRE) -- Dengan SpaceX (NASDAQ: SPCX) dijangka mula didagangkan di Nasdaq hari ini, Defiance ETFs mengesahkan bahawa Defiance Daily 2X Space ETF (Cboe: SPCL) akan menyasarkan pendedahan berleveraj harian 2X kepada saham biasa Kelas A SpaceX dalam portfolionya. Langkah ini menjadikan SPCL sebagai dana dagangan bursa (ETF) pertama dan satu-satunya di Amerika Syarikat yang mempunyai pendedahan 2X kepada SpaceX pada hari IPO. Pendedahan SpaceX dalam dana tersebut ditetapkan pada harga IPO sebanyak USD135 sesaham.

佛罗里达州迈阿密, June 13, 2026 (GLOBE NEWSWIRE) -- 随着 SpaceX (纳斯达克代码：SPCX) 预计今日在纳斯达克开始交易，Defiance ETFs 证实，旗下 Defiance Daily 2X Space ETF (芝加哥期权交易所代码：SPCL) 将寻求在其投资组合中对 SpaceX A 类普通股提供 2 倍每日杠杆风险敞口。这使得该基金成为 SpaceX 上市首日首个也是唯一一个提供 2 倍杠杆风险敞口的美国 ETF。该基金按照 135 美元的 IPO 发行价确定了对 SpaceX 的风险敞口。

미국 플로리다주 마이애미, June 13, 2026 (GLOBE NEWSWIRE) -- 우주항공기업 스페이스X(SpaceX)가 오늘 나스닥에서 종목코드 SPCX로 거래를 시작할 것으로 예상되는 가운데, Defiance ETFs는 자사의 ‘Defiance Daily 2X Space ETF (Cboe: SPCL)’가 포트폴리오 내에서 스페이스X 클래스A 보통주에 대해 일일 기준 2배 레버리지 수익률을 추종할 계획이라고 밝혔다. 이에 따라 이 ETF는 스페이스X 상장 첫날부터 스페이스X 주식에 대한 2배 레버리지 노출을 제공하는 미국 최초이자 유일한 ETF가 됐다. 펀드의 스페이스X 투자 비중은 기업공개(IPO) 공모가인 주당 135달러를 기준으로 설정됐다.

佛羅里達州邁阿密, June 13, 2026 (GLOBE NEWSWIRE) -- 預期 SpaceX (NASDAQ: SPCX) 今日將於 Nasdaq 開始買賣，Defiance ETFs 確認，Defiance Daily 2X Space ETF (Cboe: SPCL) 會在其投資組合中尋求對 SpaceX A 類普通股提供 2 倍每日槓桿曝險，令其成為首隻及唯一在上市首日提供 2 倍 SpaceX 曝險的美國交易所買賣基金 (ETF)。該基金以 135 美元的首次公開招股 (IPO) 價建立其 SpaceX 曝險。